FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Japan related Press Releases

PerkinElmer and Leading Japan Universities Announce Results of Collaboration to Detect Contamination from Nuclear Crisis

Posted January 25, 2012

Global leader in detection technologies helps researchers create new tests for radiation in water, soil and food, for safety and decontamination WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. Read more...

Ono Pharmaceutical Company Selects Medidata Rave as Enterprise EDC/CDM Solution

Posted January 18, 2012

Standard Use of Rave by Japanese Specialty Pharma Across All Trials Will Streamline Research, Accelerate Decision Making and Help Expand Global Network NEW YORK & OSAKA, Japan--(BUSINESS WIRE)-- Read more...

Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe Pharma Corporation for Japanese Market

Posted January 13, 2012

EXTON, Pa.--(BUSINESS WIRE)-- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER® vaccine to Mitsubishi Tanabe Pharma Corporation (Head Read more...

9th Annual BIO Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia

Posted January 12, 2012

Biotechnology Industry Organization (BIO) Announces Programming for 2012 Event, to Be Held in Osaka, Japan WASHINGTON--(BUSINESS WIRE)-- The BIO Asia International Conference will feature industry Read more...

QIAGEN Receives Regulatory Approval in Japan for EGFR Companion Diagnostic to Guide Cancer Treatments

Posted January 10, 2012

-- therascreen® EGFR Mutation Detection Kit RGQ approved in Japan, one of the leading markets for pairing diagnostics with drug therapies in personalized healthcareTOKYO and HILDEN, Germany, Jan. 10, Read more...

Aeterna Zentaris Partner, Yakult Honsha, Initiates Phase 1/2 Trial with Perifosine in Colorectal Cancer in Japan

Posted January 3, 2012

Trial initiation to trigger milestone payment to Aeterna Zentaris QUÉBEC CITY, Jan. 3, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its Read more...

Takeda and Affymax Provide Update on Peginesatide Commercialization Rights in Japan

Posted December 15, 2011

OSAKA, Japan & PALO ALTO, Calif.--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502) and Affymax, Inc. (Nasdaq:AFFY) today announced that Takeda has decided not to commercialize Read more...

Celgene Announces New Drug Application Filing for REVLIMID in Japan

Posted July 7, 2009

Celgene Announces New Drug Application Filing for REVLIMID® in Japan REVLIMID filing based on safety and efficacy results of two large, randomised pivotal Phase III trials, as well as specific Read more...

Shire Announces Opening of Office in Japan

Posted February 20, 2009

Shire Announces Opening of Office in Japan TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty Read more...

Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin

Posted December 8, 2008

Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin in Japan PRINCETON, N.J. & LONDON--(BUSINESS WIRE)--Bristol-Myers

Read more...